Christopher Schoonmaker

Christopher Schoonmaker is an accomplished professional with extensive experience in biostatistics and operations management within the clinical research sector. Currently serving as Chief Operating Officer at MMS since January 2023, Christopher previously held the role of Chief Operations Officer at PHASTAR. Notable positions included Vice President at Cytel, where responsibilities spanned Strategic Account Management, Clinical Research Services, and Global Head of Biostatistics. Earlier roles at inVentiv Health Clinical and Veristat, Inc. contributed to Christopher's expertise in biostatistics, with significant leadership roles. Educational qualifications include a Master of Public Health in Epidemiology and Biostatistics from Boston University and a Bachelor of Science in Chemistry from Marist College.